Skip to main content
Clinical Trials/EUCTR2015-004317-24-IT
EUCTR2015-004317-24-IT
Active, not recruiting
Phase 1

A pilot study to assess Coronary Flow Reserve and post-vasodilatatory Myocardial Blood Flow (post-Dipi gMBF), measured by 13N-NH3 PET/CT, before and after a six months-long treatment with the ACE-inhibitor Perindopril, in moderate and high-risk HCM patients”A multicentric, interventional, open label, perspective-design, single-arm, pilot” clinical Study. - CARAPaCe (CoronAry Reserve After Perindopril in hypertophic Cardiomyopathy)

AZIENDA OSPEDALIERO-UNIVERSITARIA CAREGGI0 sites21 target enrollmentSeptember 9, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hypertrophic Cardiomyopathy (primitive)
Sponsor
AZIENDA OSPEDALIERO-UNIVERSITARIA CAREGGI
Enrollment
21
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 9, 2021
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age in the range 18\-60
  • 2\. Availability of a 12\-lead rest\-ECG, performed not
  • earlier than 60 days prior to enrollment visit (EV).
  • This is called B\-ECG (Baseline\-ECG), in the following
  • 3\. Availability of a 2\-D Doppler echocardiogram,
  • performed at rest, not earlier than 60 days before of
  • EV. This is called B\-ECO (Baseline \- Ecocardiography in the following text.
  • 4\. Availability of a 13N\-NH3 PET/CT myocardial
  • perfusion scan for measurement of Myocardial Blood
  • Flow (MBF), global and regional, performed not

Exclusion Criteria

  • 1\. Women, who are pregnant or lactating
  • 2\. Women, i in childbearing age, not using an adequatecontraception (i.e., techniques having Pearl index\<2\)
  • 3\. Clinical evidence or previous clinical story of diseasescausing myocardial hypertrophy or similar
  • phenotypes:
  • a. Aortic stenosis
  • b. Cardiac amyloidosis
  • c. hemochromatosis
  • d. storage diseases
  • 4\. Coronary Artery Disease :
  • a. previous coronarography, assessing 1 or

Outcomes

Primary Outcomes

Not specified

Similar Trials